Future investigations need to be done for the pediatric patients affected by severe asthma. The choice of an appropriate biologic therapy for severe asthma is still challenging, and the importance of finding biomarkers that can predict response remains an open issue that needs to be further explored...
Yalcin AD, Cilli A, Bisgin A, Strauss LG and Herth F: Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d‑dimer, CXCL8, 25‑hydroxyvitamin D and IL‑1β levels. Expert Opin Biol Ther 13: 1335‑1341, ...
Yalcin AD, Cilli A, Bisgin A, Strauss LG, Herth F: Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1bβ levels. Expert Opin Biol Ther 2013, 13 (9):1335–1341....
Therapeutic effect of zafirlukast as monotherapy in steroid-naïve patients with severe persistent asthma Chest, 115 (1999), pp. 336-342 View in ScopusGoogle Scholar 60. SM Hassal, C Miller, A Harris Zafirlukast (Accolat™) reduces the need for oral steroid bursts Am J Respir Crit Care...
内容提示: DISEASE MANAGEMENTAlthough far from ideal, long-term systemic corticosteroids maybe necessary in treating severe refractory asthma Severe refractory asthma is a heterogeneous conditionthat presents in different patterns (e.g. frequentexacerbations, irreversible airway obstruction andreduced sensitivity...
https://doi.org/10.7556/jaoa.1993.93.3.318A ~editorials~~TreatingnocturnalasthmaposeschallengesNocturnalasthmaoccurscommonlyinpatientswithasthma.1Potentialcausesincludeexposuretodustmitesanda late-phasereactiontothisexpo-sure;theeffectsofpostureorsleepstageonair-waytoneandairwaycooling;reflux-mediatedbron-chospasm;in...
Further, LTRAs are recommended for asthmatics under specific circumstances that are closely associated with cysteinyl leukotrienes (cysLTs). Considering the low incidence of both severe adverse effects and the induction of tachyphylaxis, oral LTRAs should be more carefully considered for treating ...
The aim of this study was to develop, implement, and assess an automated asthma medication management information system (MMIS) that provides patient-specific evaluative guidance based on 1997 NAEPP clinical consensus guidelines. MMIS was developed and implemented in primary care settings within a pedia...
Asthma from Childhood to Adult Age Twenty young men with a mean age 24.9 years, who had moderate to severe asthma during childhood, underwent a follow-up examination of their clinical status... S Friberg,S Bevegård,V. GRAFF‐LONNEVIG - 《Acta Paediatrica》 被引量: 114发表: 1988年 Child...
In particular, the present disclosure has an excellent efficacy even in severe asthma patients who develop drug resistance and do not respond to drugs, accounting for about 5% of all asthma patients. BEST MODE In addition to the mechanisms known in the art in relation to the causes and treatme...